Study Details
Bryan, A. D., Schmiege, S. J., M. R. Broaddus. (2009). HIV Risk Reduction Among Detained Adolescents: A Randomized, Controlled Trial. Pediatrics, 124(6), e1180-e1188.
Schmiege, S. J., Broaddus, M. R., Levin, M., Bryan, A. D. (2009). Randomized trial of group interventions to reduce HIV/STD risk and change theoretical mediators among detained adolescents. Journal of Consulting Clinical Psychology, 77(1), 38-50.
Sexual Health and Adolescent Risk Prevention (SHARP) (formerly HIV Risk Reduction Among Detained Adolescents)
Program Information
Evaluation Setting
Study Sample
Research Design
484
4
12
Study Findings
The program was evaluated in a cluster randomized controlled trial involving adolescents from three juvenile detention facilities in Denver, CO. Small groups of adolescents were recruited on a rolling basis over a 30-month period from January 2004 to July 2006. Each group was randomly assigned to one of three conditions: (1) a treatment group that received the full intervention, (2) a treatment group that received only the first component of the intervention, the three-hour small-group session, or (3) a control group that received a one-hour small-group informational session on HIV and other sexually transmitted diseases. Surveys were administered immediately before the intervention (baseline), immediately after the intervention, and at follow-ups conducted 3, 6, 9, and 12 months after the program.
The study found that across the 3-, 6-, 9-, and 12-month follow-up surveys, condom use declined among all three of the study's research groups, but the trend in the rate of decline was significantly reduced for adolescents who received the full intervention relative to those in the control group. The study also examined program impacts on measures of alcohol problems and sexual intercourse while drinking. Findings for these outcomes were not considered for the review because they fell outside the scope of the review.
NA = Not available. This means the authors did not report the information in the manuscripts associated with the studies we reviewed.
a This information was not available whenever authors did not report information for the treatment and comparison groups separately on outcome means, standard deviations, and/or sample sizes.
b Authors reported that the program effect (impact) estimate is statistically significant with a p-value of less than 0.05 based on a two-tailed test.
c For some outcomes, having less of that outcome is favorable. In those cases, an effect with a negative sign is favorable to the treatment group (that is, the treatment group had a more favorable outcome than the comparison group, on average).
d An effect shows credibly estimated, statistically significant evidence whenever it has a p-value of less than 0.05 based on a two-tailed test, includes the appropriate adjustment for clustering (if applicable), and it is not based on an endogenous subgroup.